{"id":18035,"date":"2021-06-15T17:49:04","date_gmt":"2021-06-15T15:49:04","guid":{"rendered":"https:\/\/idibell.cat\/?p=18035"},"modified":"2021-06-16T09:38:34","modified_gmt":"2021-06-16T07:38:34","slug":"nova-catedra-per-impulsar-la-recerca-en-oncologia-radioterapica-de-precisio","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/06\/nova-catedra-per-impulsar-la-recerca-en-oncologia-radioterapica-de-precisio\/","title":{"rendered":"Nova c\u00e0tedra per impulsar la recerca en oncologia radioter\u00e0pica de precisi\u00f3"},"content":{"rendered":"
La recerca en el marc de la nova c\u00e0tedra se centrar\u00e0 en tres l\u00ednies principals: la personalitzaci\u00f3 dels tractaments amb radioter\u00e0pia mitjan\u00e7ant estudis de radiosensibilitat i de radiotoxicitat, el diagn\u00f2stic predictiu previ al tractament de radioter\u00e0pia d\u2019alta precisi\u00f3, i l\u2019efecte de la radioter\u00e0pia en la resposta immunit\u00e0ria enfront del c\u00e0ncer.<\/p>\n
<\/p>\n
L\u2019acte de signatura ha estat presidit pel rector de la Universitat de Barcelona, Joan Gu\u00e0rdia, que en la presentaci\u00f3 posterior ha destacat que \u00abaquesta c\u00e0tedra cont\u00e9 una combinaci\u00f3 d\u2019ingredients \u2014institucions p\u00fabliques, empresa, coneixement i \u00e8tica\u2014 que faran que tingui un \u00e8xit cient\u00edfic segur i un comprom\u00eds de futur que permetr\u00e0 passar de la ter\u00e0pia massiva a la personalitzada, i de parlar de malaltia a parlar de persones malaltes\u00bb.<\/p>\n
<\/p>\n
Per la seva banda, Ferran Guedea<\/strong>, cap del Grup de Radiobiologia i C\u00e0ncer<\/a> de l’IDIBELL, catedr\u00e0tic del Departament de Ci\u00e8ncies Cl\u00edniques de la UB i director d\u2019Oncologia Radioter\u00e0pica de l\u2019ICO , que dirigir\u00e0 la nova c\u00e0tedra, ha explicat: \u00abAquesta c\u00e0tedra organitzar\u00e0, entre altres activitats, un simposi de recerca translacional en oncologia radioter\u00e0pica i es premiaran els millors treballs presentats. Tamb\u00e9 es promocionaran l\u00ednies de recerca com els estudis predictius de radiotoxicitat i radiosensibilitat, i la resposta immunit\u00e0ria a altes dosis de radioter\u00e0pia\u00bb. Finalment, Santiago de Torres, president d\u2019Atrys Health<\/a>, ha posat \u00e8mfasi en la import\u00e0ncia que tenen per a la companyia \u00abla recerca i la medicina translacional, especialment en l\u2019\u00e0mbit de la radioter\u00e0pia hipofraccionada o d\u2019alta precisi\u00f3\u00bb.<\/p>\n <\/p>\n <\/p>\n Entre les accions que es duran a terme per complir els objectius esmentats, cal destacar la convocat\u00f2ria dels Premis Nacionals de Recerca en Radioter\u00e0pia Personalitzada, uns guardons que premiaran anualment els tres millors articles de recerca publicats en reconegudes revistes cient\u00edfiques i en qu\u00e8 el primer o l\u2019\u00faltim autor pertanyin a un grup de recerca establert a Espanya.<\/p>\n <\/p>\n A m\u00e9s, en el marc d\u2019aquesta activitat formativa, se celebrar\u00e0 una confer\u00e8ncia anual d\u2019aven\u00e7os en recerca translacional en radioter\u00e0pia, amb la participaci\u00f3 d\u2019un ponent de rellev\u00e0ncia internacional i que servir\u00e0 de f\u00f2rum per a la presentaci\u00f3 i lliurament dels premis.<\/p>\n <\/p>\n <\/p>\n L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" La UB i la companyia biom\u00e8dica Atrys Health, especialitzada en medicina de precisi\u00f3, han signat avui un conveni de col\u00b7laboraci\u00f3 per crear la C\u00e0tedra de Radioter\u00e0pia Personalitzada, que estar\u00e0 liderada per Ferran Guedea, cap del Grup de Radiobiolog\u00eda y C\u00e1ncer de l’IDIBELL.<\/p>\n","protected":false},"author":8,"featured_media":18037,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[332,447,372],"tags":[],"class_list":["post-18035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell","category-radiobiologia-i-cancer"],"publishpress_future_action":{"enabled":false,"date":"2024-09-14 23:04:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/18035"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=18035"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/18035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/18037"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=18035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=18035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=18035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Premis Nacionals de Recerca en Radioter\u00e0pia Personalitzada<\/h3>\n